Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke

Journal of Clinical Immunology

Volumn 21, Issue 5, 2001, Pages 365-375

  Kouwenhoven, M ^a   Carlstrom C ^a   Ozenci V ^a   Link, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytokines; ELISPOT; Metalloproteinases; Monocytes; Stroke; Zymography

Indexed keywords

MATRIX METALLOPROTEINASE;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONVALESCENCE; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATORY INFILTRATE; MALE; MONOCYTE; MONONUCLEAR CELL; NERVE INJURY; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROKE; ZYMOGRAPHY;

AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; MONOCYTES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0034763457     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012244820709     Document Type: Article

References (48)

1. Inflammation and glial responses in ischemic brain lesions
2. Potential mechanisms of interleukine-1 involvement in cerebral ischaemia
3. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion
4. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia
5. Advances in the vascular pathophysiology of ischemic stroke
6. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke
7. Intrathecal release of pro- and antiinflammatory cytokines during stroke
8. The role of cytokines in the neuropathology of stroke and neurotrauma
9. Glial expression of cytokines in the brains of cerebrovascular disease patients
10. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: Kinetics of secretion and relation to the extent of brain damage and outcome of disease
11. Interleukin-6 and interleuki-1 receptor antagonist in acute stroke
12. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke
13. Cytokines and cell adhesion molecules in cerebral ischemia. Experimental bases and therapeutic perspectives
14. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumor necrosis factor-alpha inhibitor
15. Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis
16. Extracellular matrix degradation by metalloproteinases and central nervous system diseases
17. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion
18. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke
19. The matrix metalloproteinases and their natural inhibitors: Prospects for treating degenerative tissue diseases
20. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
21. Classification and natural history of clinically identifiable subtypes of cerebral infarction
22. Monocytes in multiple sclerosis: Phenotype and cytokine profile
23. Reverse ELISPOT assay for clinical analysis of cytokine production. I. Enumeration of gamma-interferon secreting cells
24. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment
25. Organ-specific autoantigens induce interferon-gamma and interleukine-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis
26. The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin
27. Immune regulation within the central nervous system
28. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke
29. The matrix degrading metalloproteinases
30. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: An overview
31. IL-12 in autoimmunity
32. A novel function of IL-12p40 as a chemotactic molecule for macrophages
33. IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients
34. The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion
35. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts
36. Cytokine and chemokine regulation of pro-MMP-9 and TIMP-1 production by human peripheral blood lymphocytes
37. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T cell lymphoma/endothelial cell contact: Implication of ICAM-1
38. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinase-1/eruthroid potentiating activity (TIMP-1/EPA)
39. Interleukin-10
40. High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases
41. Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN-γ and TNF-α in human blood
42. Cloning and characterization of human tumor cell interstitial collagenase
43. H-ras oncogene-transformed bronchial epithelial cells (TBE-1), secrete a single metalloproteinase capable of degrading basement membrane collagen
44. Structure and expression of the human gene for the matrix metalloproteinase matrilysin
45. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human
46. Characterization of a human corneal metalloproteinase inhibitor (TIMP-1)
47. Metastasis suppressor genes